LivaNova PLC (LIVN) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $84.60M; Additional Paid in Capital, Common StockUSD $2.27B; Treasury Stock, Common, ValueUSD $732.00K; Treasury Stock, ValueUSD (m).
- 2026-03-31: Common Stock, Value, IssuedUSD $84.56M; Additional Paid in Capital, Common StockUSD $2.25B; Treasury Stock, Common, ValueUSD $1.17M; Treasury Stock, ValueUSD (m).
- 2025-12-31: Common Stock, Value, IssuedUSD $84.56M; Additional Paid in Capital, Common StockUSD $2.25B; Treasury Stock, Common, ValueUSD $1.17M; Treasury Stock, ValueUSD (m).
- 2025-09-30: Common Stock, Value, IssuedUSD $84.52M; Additional Paid in Capital, Common StockUSD $2.25B; Treasury Stock, Common, ValueUSD $1.20M; Treasury Stock, ValueUSD (m).
LivaNova PLC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Preferred Stock, Value, Issued USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Retired, Cost Method, Amount USD | Treasury Stock, Shares, Retired shares | Adjustments to Additional Paid in Capital, Other USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $84.60M | $2.27B | $732.00K | (m) | $-14.39M | $-1.01B | $1.33B | 549.38K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $84.56M | $2.25B | $1.17M | (m) | $-3.40M | $-1.12B | $1.21B | 636.43K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $84.56M | $2.25B | $1.17M | (m) | $7.33M | $-1.15B | $1.20B | 886.10K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $84.52M | $2.25B | $1.20M | (m) | $5.51M | $-1.18B | $1.16B | 897.99K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $84.52M | $2.23B | $1.16M | (m) | $8.11M | $-1.20B | $1.12B | 908.44K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $84.45M | $2.22B | $1.43M | (m) | $-42.73M | $-1.23B | $1.03B | 918.22K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $83.16M | $2.22B | $136.00K | $136.00K | $-80.17M | $-903.25M | $1.32B | 89.13K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $83.11M | $2.21B | $156.00K | (m) | $-26.70M | $-959.14M | $1.31B | 105.70K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $83.07M | $2.20B | (m) | $195.00K | $-52.82M | $-992.09M | $1.24B | 107.90K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $82.97M | $2.19B | (m) | $481.00K | $-45.21M | $-1.01B | $1.22B | 147.03K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $82.53M | $2.19B | $55.00K | $55.00K | $-27.88M | $-966.48M | $1.28B | 23.93K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $82.49M | $2.18B | (m) | $56.00K | $-54.80M | $-982.82M | $1.23B | 42.92K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $82.44M | $2.17B | (m) | $95.00K | $-35.58M | $-975.50M | $1.24B | 73.18K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $82.42M | $2.16B | (m) | $319.00K | $-41.03M | $-976.66M | $1.23B | 90.53K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $82.42M | $2.16B | (m) | $375.00K | $-48.12M | $-984.03M | $1.21B | 287.31K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 287.31K |
| 2022-09-30 | $82.38M | $2.14B | (m) | $380.00K | $-93.10M | $-985.69M | $1.15B | 291.42K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $82.36M | $2.13B | (m) | $397.00K | $-54.87M | $-878.35M | $1.28B | 304.01K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $82.30M | $2.12B | (m) | $619.00K | $-16.13M | $-894.79M | $1.29B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 327.68K |
| 2021-12-31 | $82.30M | $2.12B | (m) | $650.00K | $-7.18M | $-897.78M | $1.29B | 498.21K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 498.21K |
| 2021-09-30 | $82.25M | $2.11B | (m) | $671.00K | $3.18M | $-879.65M | $1.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 510.59K |
| 2021-06-30 | $76.41M | $1.78B | (m) | $705.00K | $23.07M | $-837.42M | $1.03B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 539.30K |
| 2021-03-31 | $76.31M | $1.77B | (m) | $798.00K | $1.94M | $-782.10M | $1.06B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 610.18K |
| 2020-12-31 | $76.30M | $1.77B | (m) | $1.03M | $27.81M | $-761.97M | $1.11B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 791.61K |
| 2020-09-30 | $76.34M | $1.76B | (m) | $1.05M | $-10.38M | $-472.58M | $1.35B | (m) | (m) | (m) | (m) | (m) | 3 month · 73.00K 9 month · 73.00K | (m) | (m) | (m) | (m) | (m) | (m) | 806.21K |
| 2020-06-30 | $76.34M | $1.75B | (m) | $1.06M | $-35.09M | $-457.80M | $1.33B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 809.02K |
| 2020-03-31 | $76.26M | $1.74B | (m) | $1.09M | $-52.52M | $-369.81M | $1.39B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 835.00K |
| 2019-12-31 | $76.26M | $1.73B | (m) | $1.26M | $-19.39M | $-406.75M | $1.38B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 967.19K |
| 2019-09-30 | $76.22M | $1.73B | (m) | $1.28M | $-41.61M | $-263.52M | $1.50B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 981.47K |
| 2019-06-30 | $76.22M | $1.72B | (m) | $1.29M | (m) | $-295.64M | $1.48B | (m) | (m) | $-13.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 989.21K |
| 2019-03-31 | $76.15M | $1.71B | (m) | $1.32M | (m) | $-266.43M | $1.49B | (m) | (m) | $-28.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.01M |
| 2018-12-31 | $76.14M | $1.71B | (m) | $1.46M | $-24.48M | $-251.58M | $1.50B | (m) | (m) | $-24.48M | 12 month · $50.00M | (m) | (m) | (m) | (m) | 12 month · 99.91 | (m) | (m) | (m) | 1.12M |
| 2018-09-30 | $75.31M | $1.75B | (m) | $28.00K | (m) | $-40.93M | $1.78B | (m) | (m) | $-245.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 13.48K |
| 2018-06-30 | $75.27M | $1.74B | (m) | $109.00K | (m) | $-33.76M | $1.78B | (m) | (m) | $-2.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 77.37K |
| 2018-03-31 | $75.22M | $1.74B | (m) | $375.00K | (m) | $-48.82M | $1.82B | (m) | (m) | $54.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 199.13K |
| 2018-01-01 | (m) | (m) | (m) | (m) | (m) | $-62.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $74.75M | $1.74B | (m) | $133.00K | $45.31M | $-39.66M | $1.82B | (m) | (m) | $45.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.93K |
| 2017-09-30 | $74.70M | $1.73B | (m) | $2.33M | (m) | $72.02M | $1.91B | (m) | (m) | $38.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 50.10K |
| 2017-06-30 | $74.65M | $1.73B | (m) | $2.43M | (m) | $44.19M | $1.84B | (m) | (m) | $870.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 52.26K |
| 2017-03-31 | $74.61M | $1.72B | (m) | $2.65M | (m) | $-3.30M | $1.73B | (m) | (m) | $-54.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 60.01K |
| 2016-12-31 | $74.58M | $1.72B | (m) | $4.50M | $-68.49M | $-14.57M | $1.71B | (m) | (m) | $-68.49M | 5 month · $50.00M 12 month · $50.00M | (m) | (m) | (m) | (m) | 5 month · 50.32 12 month · 50.32 | 12 month · $-567.00K | 12 month · $-971.00K | (m) | 128.28K |
| 2016-09-30 | $75.54M | $1.75B | (m) | (m) | (m) | $15.22M | $1.82B | (m) | (m) | $-25.34M | 1 month · $12.90M | (m) | (m) | (m) | (m) | 1 month · 60.44 | (m) | (m) | (m) | (m) |
| 2016-06-30 | $75.73M | $1.76B | (m) | (m) | (m) | $16.79M | $1.82B | (m) | (m) | $-24.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $75.64M | $1.75B | (m) | (m) | $-9.11M | $7.84M | $1.83B | (m) | (m) | $-9.11M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-115.00K | 3 month · $-134.00K | (m) | (m) |
| 2015-12-31 | $75.44M | $1.74B | (m) | $0.00 | $-54.23M | $48.21M | $1.81B | (m) | (m) | $-54.23M | (m) | (m) | (m) | 8 month · $0.00 | (m) | (m) | 8 month · $0.00 | 8 month · $0.00 | (m) | (m) |
| 2015-10-19 | (m) | (m) | (m) | (m) | (m) | (m) | $74.43M | (m) | (m) | (m) | (m) | 6 month · $7.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-10-18 | $321.41K | $466.46M | (m) | $250.88M | (m) | $65.15M | $278.39M | (m) | $0.00 | $-2.67M | 6 month · $7.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.17M |
| 2015-09-30 | $0.00 | (m) | (m) | (m) | (m) | $1.00K | $76.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-04-24 | $321.00K | $445.36M | (m) | $243.53M | $-3.40M | $77.83M | $276.57M | (m) | $0.00 | $-3.40M | 12 month · $55.02M | (m) | (m) | (m) | 3 month · 129.22K 12 month · 875.12K | 3 month · 58.01 12 month · 55.94 | 3 month · $0.00 | 3 month · $0.00 | 12 month · $4.53M | 6.06M |
| 2015-01-23 | (m) | (m) | (m) | (m) | $-2.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-10-24 | (m) | (m) | (m) | (m) | (m) | (m) | $269.89M | (m) | (m) | (m) | 6 month · $29.07M | (m) | (m) | (m) | 3 month · 280.20K | 3 month · 54.54 | (m) | (m) | (m) | (m) |
| 2014-04-25 | $318.00K | $426.87M | (m) | $188.52M | (m) | $19.98M | $259.10M | (m) | (m) | $455.00K | 12 month · $72.36M | (m) | (m) | (m) | 12 month · 1.21M | 12 month · 57.66 | (m) | (m) | 12 month · $27.07M | 6.06M |
| 2013-04-26 | (m) | (m) | (m) | (m) | (m) | (m) | $229.57M | (m) | (m) | (m) | 12 month · $33.01M | (m) | (m) | (m) | 12 month · 600.00K | 12 month · 45.58 | (m) | (m) | 12 month · $12.36M | 5.07M |
| 2012-04-27 | (m) | (m) | (m) | (m) | (m) | (m) | $183.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |